Ultragenyx Pharma (RARE) PT Raised to $48 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.52 -1.27%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 9
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $48.00 (from $47.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Packaging Corp. of America (PKG) PT Raised to $292 at UBS Following Containerboard Price Increase
- Cisco (CSCO) PT Raised to $135 at KeyBanc
- Cisco (CSCO) PT Raised to $138 at UBS on Profit Growth Expectations
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
